MGP Ingredients, Inc’s filing revealed that its Director Seaberg Karen acquired Company’s shares for reported $0.54 million on Dec 11 ’24. In the deal valued at $45.60 per share,11,843 shares were bought.
Then, Seaberg Karen bought 5,264 shares, generating $240,039 in total proceeds.
Before that, Mingus Lori L.S. bought 1,530 shares. MGP Ingredients, Inc shares valued at $138,083 were divested by the Director at a price of $90.25 per share.
TD Cowen downgraded its MGP Ingredients, Inc [MGPI] rating to a Hold from a a Buy in a research note published on November 06, 2024; the price target was decreased to $50 from $66. A number of analysts have revised their coverage, including Lake Street’s analysts, who decreased its forecast for the stock in mid October from “a Buy” to “a Hold”. Wedbush began covering MGPI with “an Outperform” recommendation on October 11, 2022. Wells Fargo started covering the stock on August 15, 2022. It rated MGPI as “an Overweight”.
Price Performance Review of MGPI
On Tuesday, MGP Ingredients, Inc [NASDAQ:MGPI] saw its stock fall -0.73% to $32.59. Over the last five days, the stock has lost -0.46%. MGP Ingredients, Inc shares have fallen nearly -17.22% since the year began. Nevertheless, the stocks have fallen -58.31% over the past one year. While a 52-week high of $92.52 was reached on 01/06/25, a 52-week low of $31.76 was recorded on 02/24/25. SMA at 50 days reached $36.86, while 200 days put it at $63.91.
Levels Of Support And Resistance For MGPI Stock
The 24-hour chart illustrates a support level at 32.07, which if violated will result in even more drops to 31.54. On the upside, there is a resistance level at 33.26. A further resistance level may holdings at 33.92. The Relative Strength Index (RSI) on the 14-day chart is 37.52, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.24, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.26%. Stochastics %K at 25.93% indicates the stock is a holding.
The most recent change occurred on June 30, 2022 when ROTH Capital began covering the stock and recommended ‘”a Buy”‘ rating along with a $115 price target.
